E
Titan Pharmaceuticals, Inc. TTNP
$4.99 $0.091.84% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue -- --
Gross Profit -- --
SG&A Expenses 23.03% -19.82%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 23.03% -19.82%
Operating Income -23.03% 19.82%
Income Before Tax -22.38% 28.73%
Income Tax Expenses -- --
Earnings from Continuing Operations -22.38% 28.73%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -22.38% 28.73%
EBIT -23.03% 19.82%
EBITDA -23.09% 20.00%
EPS Basic -5.02% 28.73%
Normalized Basic EPS -5.01% 28.73%
EPS Diluted -5.02% 28.73%
Normalized Diluted EPS -5.01% 28.73%
Average Basic Shares Outstanding 16.52% 0.00%
Average Diluted Shares Outstanding 16.52% 0.00%
Dividend Per Share -- --
Payout Ratio -- --